Overview

Chloroquine for Glioblastoma.

Status:
Active, not recruiting
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
Adjuvant chloroquine to the conventional treatment for glioblastoma; A randomized, single-blind, placebo-controlled, phase I/II trial.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Egyptian Medical Syndicate